Summary
Michael Laffan is Professor of Haemostasis and Thrombosis in the department of haematology.He trained in medicine at the University of Oxford and trained in haematology at the Hammersmith and Royal Free hospitals. His principal research interests are the structure function relationship of von Willebrand factor, in particular the role of glycosylation, and the mechanisms and regulation of thrombin generation. He is director of the Hammersmith Hospital Haemophilia centre and is responsible for postgraduate education in haematology.
Publications
Journals
Morrow GB, Flannery S, Charles PD, et al., 2024, A novel method to quantify fibrin-fibrin and fibrin-α2AP cross-links in thrombi formed from human trauma patient plasma., J Thromb Haemost
Laffan M, McLaughlin P, Motwani J, et al., 2024, Expert United Kingdom consensus on the preservation of joint health in people with moderate and severe haemophilia A: A modified Delphi panel., Haemophilia, Vol:30, Pages:306-319
Symington E, Rangarajan S, Lester W, et al., 2024, Long-term safety and efficacy outcomes of valoctocogene roxaparvovec gene transfer up to 6 years post-treatment., Haemophilia, Vol:30, Pages:320-330
Arachchillage DJ, Thachil J, Anderson JAM, et al., 2024, Diagnosis and management of heparin-induced thrombocytopenia: Third edition., Br J Haematol, Vol:204, Pages:459-475
Mitchell JL, Khan D, Rana RH, et al., 2023, Multiple myeloma and its treatment contribute to increased platelet reactivity, Platelets, Vol:34, ISSN:0953-7104